Gene Query: KANSL2

Dataset Description Geneva Score
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 26.49
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 20.04
Tracking of dCas9-methyltransferase footprints 19.46
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 18.33
Uridylation by TUT4 and TUT7 marks mRNA for degradation 16.96
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 13.52
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 13.33
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 13.33
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 13.01
SETBP1-WT and SETBP1-G870S epigenetic landscapes 13.01
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 12.29
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 12.27
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 12.24
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 11.65
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 10.83
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 10.83
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 10.76
R430: A potent inbibitor of DNA and RNA viruses 10.64
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 10.64
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 10.63
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 10.63
Cajal bodies are linked to genome conformation [RNA-Seq] 10.41
Cajal bodies are linked to genome conformation 10.41
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 10.27
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 10.27
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 10.0
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 10.0
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 9.73
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 9.73
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 9.56
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 9.56
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 9.51
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 9.51
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 9.36
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 9.27
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 9.25
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 9.2
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 9.09
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 8.86
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 8.86
Transcriptional profile in human S. haematobium infection 8.81
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 8.79
Genome wide miR-191 target profile determined by RIP and gene expression profiling 8.79
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 8.74
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 8.71
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 8.44
Unique features and clinical importance of acute alloreactive immune responses 8.33
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 8.2
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 8.2
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 8.19
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 8.1
Seletive inhibition of CDK9 in DLBCL cell lines 8.04
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 7.99
Effect of BB608 on Gene Expression in HNSCC Cell Line 7.9
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 7.9
Identification of a LIF-responsive replication-competent human β cell 7.76
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 7.75
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 7.75
Expression by CD133+ cells isolated from the adult human exocrine pancreas 7.74
Modulation of nonsense-mediated decay by rapamycin 7.72
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 7.72
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 7.67
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 7.67
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 7.54
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 7.44
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 7.21
UV_24h_GRO-Seq 7.06
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 7.05
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 7.04
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 6.9
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 6.81
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 6.8
m6A-dependent regulation of messenger RNA stability 6.68
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 6.66
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 6.6
RNA-seq analyisis of PUM2 knockout cells 6.49
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 6.36
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 6.34
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 6.34
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 6.33
DART-seq: an antibody-free method for global m6A detection 6.04
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.96
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 5.91
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 5.9
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 5.82
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 5.78
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 5.74
RNA-seq of IL-4 stimulated human keratinocytes 5.68
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 5.64
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 5.62
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 5.58
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 5.58
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 5.54
RNAseq of HEK293 cells after Chtop knockdown 5.42
Co-transcriptional loading of RNA export factors shapes the human transcriptome 5.42
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 5.38
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 5.36
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 5.33
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 5.33
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 5.32
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 5.19
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 5.19
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 5.17
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 5.17
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 5.17
mRNA expression profile of Lymphocytes 5.11
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 5.04
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 5.0
SLAM-seq for K562 endogenous mRNA decay 4.98
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.98
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.98
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 4.98
Noncoding regions are the main source of targetable tumor-specific antigens 4.96
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 4.96
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 4.96
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 4.9
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 4.86
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 4.85
Mapping interactions for the TNIP2 hub protein 4.85
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 4.83
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 4.83
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 4.81
Differentially expressed genes post knock down of lincDUSP26 4.71
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 4.69
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 4.68
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 4.67
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 4.66
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 4.56
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 4.55
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 4.52
Tracking distinct RNA populations using efficient and reversible covalent chemistry 4.49
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 4.44
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.42
Capturing the Interactome of Newly Transcribed RNA 4.42
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 4.41
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 4.4
Effect of CHKA knockdown on C4-2 cell transcriptome 4.33
TGF-β regulation of miRNA expression in pancreatic cancer 4.33
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 4.3
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 4.28
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 4.27
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 4.2
Short and Long RNA sequencing of human mature erythrocytes 4.17
Human Treg NaCl stimulation 4.17
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 4.15
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 4.13
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.12
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.12
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 4.1
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 4.08
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 4.03
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 4.02
A Unique Epigenomic Landscape Defines Human Erythropoiesis 4.02
MAIT cell RNA sequencing 3.98
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 3.93
Intrahepatic MAIT cell gene expression revealed by RNA-seq 3.92
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.9
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 3.86
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 3.85
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 3.85
Total RNA-seq in ALL-SIL upon TLX1 knockdown 3.78
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 3.78
RNA-seq of tumor cells following angiopellosis extravasation 3.77
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 3.75
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 3.73
T47D RNA-seq and ChrRNA-seq data 3.73
Functional significance of the HIV-1 Tat signature amino acid residues 3.73
RNA-seq of YB5 cells treated with Proscillaridin A 3.73
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 3.71
Identification of global regulators of T-helper cell lineage specification 3.71
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 3.71
Glioblastoma stem cells infected by ZIKA virus 3.68
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 3.67
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 3.67
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 3.66
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 3.65
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 3.64
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 3.6
Effect of drugs on transcriptomic profiles 3.57
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 3.57
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 3.56
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 3.56
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 3.54
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 3.54
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 3.51
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 3.5
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 3.5
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 3.47
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.47
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 3.46
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 3.45
CircRNAome diversity in human mature B-cells, T-cells and monocytes 3.44
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 3.42
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 3.41
The cohesin complex prevents Myc-induced replication stress 3.39
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 3.38
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 3.38
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 3.37
Gene expression signatures of innate lymphoid cells from human blood 3.37
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 3.36
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 3.36
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 3.35
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 3.35
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 3.35
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 3.34
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 3.32
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 3.31
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 3.29
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 3.28
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.26
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 3.25
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 3.22
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 3.22
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 3.2
RNA transcriptome analysis during HSV-1 infection 3.19
Rorc disruption in human FG pancreatic cancer cells 3.19
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 3.16
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 3.16
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 3.15
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 3.14
MYC dependent mRNA translation shapes gene expression and cell biology 3.13
4sUDRB-seq: measuring transcription elongation and initiation genomewide 3.13
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 3.11
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 3.11
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 3.11
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 3.1
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 3.09
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 3.09
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 3.05
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 3.04
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 3.04
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 3.03
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 3.02
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 3.01
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 3.01
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 3.0
ARID1A regulates condensin II distribution and chromosomal partition 3.0
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 2.95
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 2.95
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 2.93
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 2.92
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 2.92
RNA-Seq from human ILC transitional populations 2.92
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 2.85
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 2.84
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.79
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 2.79
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 2.78
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 2.78
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 2.73
ETV7 and interferon response 2.72
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 2.72
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 2.71
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 2.7
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.69
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 2.68
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 2.67
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 2.65
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 2.64
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.61
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 2.61
Identification of HOXB13 target genes responsive to BET inhibitors 2.56
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 2.56
The transcriptome and chromatin accessbility landscape of mammalian germline 2.56
Silencing p300 in MCF7 cells to study expression and alternative splicing 2.55
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 2.53
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 2.52
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 2.51
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 2.51
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 2.5
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 2.5
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 2.5
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 2.5
Gene expression analysis of the impact of TDP-43 knockout in human cells. 2.47
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 2.45
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 2.45
An optimization system for isolating and sequencing of single human colon cancer cells 2.44
Genome-wide discovery of human splicing branchpoints 2.43
LncRNA expression profiling of ischemic stroke patients 2.41
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 2.4
NKX2.2 2.4
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 2.37
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 2.33
LIN28A modulates splicing and gene expression programs in breast cancer cells 2.32
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 2.32
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.31
Transcriptome-wide modulation of splicing by the exon junction complex 2.29
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.29
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 2.28
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 2.27
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 2.26
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 2.26
Gene expression in GBM with Cav3.2 inhibition 2.22
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.21
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 2.21
Determining mRNA half-lives on a transcriptome-wide scale 2.19
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 2.18
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 2.15
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 2.15
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.13
Effect of PBK knockdown on C4-2 cell transcriptome 2.13
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.12
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 2.12
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 2.11
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 2.11
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 2.09
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 2.08
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 2.08
Loss of CREBBP results in gene expression repression in lymphoma cells 2.06
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 2.06
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 2.04
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.03
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 2.0
Transcriptional landscape changes during human embryonic stem cell derivation 1.99
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.93
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 1.91
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.91
Controlling for gene expression changes in transcription factor protein networks. 1.9
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 1.89
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.89
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 1.87
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 1.87
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 1.87
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 1.85
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 1.85
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 1.85
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 1.85
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 1.84
Retinoic acid suppresses MYB in adenoid cystic carcinoma 1.84
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 1.84
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 1.84
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 1.84
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 1.84
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 1.84
quanTIseq: quantifying immune contexture of human tumors 1.81
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 1.79
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 1.79
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 1.78
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 1.73
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.73
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.72
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.72
Next generation sequencing of small RNAs isolated from exosomes in human semen 1.71
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.66
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.66
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 1.65
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 1.64
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 1.64
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.61
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.58
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.58
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.54
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.52
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.52
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 1.52
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.52
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 1.51
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.5
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 1.47
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 1.47
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 1.46
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 1.46
mRNA expression profile of Lymphocytes by high-throuput sequencing 1.43
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 1.43
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 1.43
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.43
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.43
RNA sequencing of human mammary epithelial cells 1.42
Trans-differentiation of human adult peripheral blood T cells into neurons 1.42
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.42
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 1.41
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 1.39
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 1.39
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 1.33
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 1.3
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 1.29
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.27
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.24
RNA expression analysis upon JMJD1C depletion 1.23
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 1.23
Gene expression profile in breast cancer cells 1.23
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.23
RNAseq of T-ALL upon long non coding rna purturbation 1.22
O-glcnAc reprograms cellular energetics 1.21
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.2
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.2
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.18
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 1.18
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.17
RNA-Seq in neutrophils from Antiphospholipid Syndrome 1.15
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.14
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 1.12
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 1.12
6mer seed toxicity in tumour suppressive microRNAs 1.12
Differential Protein Occupancy Profiling of the mRNA Transcriptome 1.12
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 1.1
Human Treg IFNg/IL-10 subpopulations 1.1
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.09
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 1.09
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.08
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 1.08
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.08
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 1.07
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.07
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.07
Identification of renal resident macrophages across species [C1] 1.06
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.05
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.05
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 1.04
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.04
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.04
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 1.03
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.02
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.02
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.02
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.01
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.99
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.99
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 0.95
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.93
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 0.91
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.91
Transposon-based construction of strand-specific RNA-seq libraries 0.89
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.89
Genome-wide analysis of the Integrator complex 0.83
Genome-wide analysis of the Integrator complex (HTS) 0.83
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 0.82
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.82
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.81
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.79
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.78
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 0.77
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 0.77
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.76
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.75
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.73
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.7
RNA-seq of primary patient AML samples 0.69
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 0.69
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.68
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.68
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.67
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.66
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.65
mRNA recovered upon RNF219 IP. [RNA-IP] 0.63
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.62
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.55
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.54
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.53
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.5
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.49
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.48
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.48
Leucegene: AML sequencing (part 6) 0.45
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.45
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.44
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 0.43
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.42
High-resolution comparative analysis of great ape genomes 0.42
Enhancer activation during EGF response 0.4
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.39
Modeling Human Cancer-induced Cachexia (Human) 0.39
Human Treg IL-12 stimulation 0.37
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.35
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.35
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 0.34
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 0.34
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.32
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.3
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.28
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.28
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.28
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.28
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.27
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.27
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.26
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.26
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.25
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.25
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 0.23
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.22
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 0.22
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.21
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 0.17
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.16
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.16
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.14
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.1
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.07
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.06
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.06
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.05
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.04
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.04
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.03
HEK293 TFAM Knockout Expression Study 0.02
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.01
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.01
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.01
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation